ArticlePloS one2026
A hybrid mamba-transformer architecture fusing clinical and genetic features for gestational diabetes mellitus prediction.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Gestational diabetes mellitus (GDM) is a common disorder of glucose metabolism during pregnancy. Early GDM prediction is crucial for reducing adverse maternal and neonatal outcomes. This paper proposes a hybrid Mamba-Transformer architecture that aggregates clinical and genetic features for GDM prediction. First, a correlation-driven weighted fusion method for clinical and genetic features is introduced. The integrated representation not only enhances feature representation but also highlights the interactive relationship between genetic susceptibility and clinical factors. Second, a sliding window approach is applied to reconstruct the sample sequences from the preprocessed data, generating augmented instances as model input. This transforms isolated individual features into context-aware group features, enabling the effective capture of both population-level heterogeneity and individual risk. Finally, the hybrid Mamba-Transformer architecture is constructed and trained on the publicly available competition dataset (DMRPD) from the Alibaba Cloud Tianchi platform. The model employs a modular and extensible encoder-decoder structure, where the Mamba module serves as an efficient feature extractor for dependencies, while the Transformer module performs deep semantic modeling and sequence abstraction. Experimental results indicate that the proposed method achieves competitive performance compared with other representative models. Specifically, the model attained an AUC of 0.825 on the test set, with sensitivity and specificity at the optimal threshold (0.526) of 0.827 and 0.729, respectively, suggesting reliable discriminative performance on the test set. These findings suggest that the proposed method may provide a useful approach for early GDM risk prediction and could potentially support more targeted screening strategies. However, further validation using larger and independent cohorts is required to confirm its generalizability and clinical applicability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.